Students at Lewis Katz School of Medicine stand to benefit from new $1 million NIGMS grant
Rapid evolution in the field of biomedical research demands well-trained scientists. Adapting biomedical research training programs to keep up with the increasingly complex and interdisciplinary nature of the field, however, presents complex challenges for higher-education institutions.
The Lewis Katz School of Medicine at Temple University, home to highly skilled researchers and professors and known for its collaborative atmosphere, has long been on the cutting edge of biomedical research. Now, PhD and MD/PhD students in the Biomedical Sciences Graduate Program at Temple stand to benefit even further from these in-house resources, gaining unprecedented opportunities to learn from researchers across multiple departments, thanks to a new $1 million T32 predoctoral training grant from the National Institute of General Medical Sciences (NIGMS) within the National Institutes of Health (NIH).
John-karanicolas
Kellya-whelan
Jonathan-soboloff
Emily-henderson
Biomedical-sciences-graduate-program-at-temple
National-institutes-of-health
Soboloff-is-co
Fels-cancer-institute-for-personalized-medicine
Dean-of-the-graduate-md-phd-program
Katz-school-of-medicine
Fox-chase-cancer-center
National-institute
Everspring and Yeshiva University Expand Fully Digital Experience to MBA Program
Innovation and engagement are at the core of the successful online learning platform
News provided by
Share this article
Share this article
NEW YORK, May 11, 2021 /PRNewswire/ Everspring Inc., a leading provider of education technology and services to universities seeking to build or expand their online capabilities, announced today it has significantly expanded its relationship with Yeshiva University to include the Sy Syms School of Business. The expansion includes taking the highly respected Sy Syms MBA program fully digital.
Sy Syms is the fourth school at Yeshiva to entrust its digital presence to Everspring. The other partner schools include the Wurzweiler School of Social Work, the Benjamin N. Cardozo School of Law, and the Katz School of Science and Health.
New-york
United-states
Brookdale
Yeshiva-university
Chicago
Illinois
Beth-hollenberg
Noam-wasserman
Mark-finkel
Sy-syms
Ferkauf-graduate-school-of-psychology
Katz-school-of-science
Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy
For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders. In 2017 alone, some 18 million Americans misused prescription pain relievers over the course of the previous year. In many of these instances, patients suffering from chronic pain became addicted to prescription opioids.
In addition to being highly addictive, many studies suggest that prescription opioids do not effectively control pain over the long term, and hence researchers have been exploring various alternatives, including cannabidiol (CBD). CBD is a non-psychoactive substance derived from the Cannabis plant.
Pennsylvania
United-states
United-kingdom
Americans
British
Emily-henderson
Neuropathix-inc
Katz-school-of-medicine
Lewis-katz-school
Temple-university
Sara-jane-ward
Assistant-professor
E-Mail
IMAGE: Sara Jane Ward, PhD, Assistant Professor of Pharmacology at the Lewis Katz School of Medicine at Temple University. view more
Credit: Temple University Health System
(Philadelphia, PA) - For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders. In 2017 alone, some 18 million Americans misused prescription pain relievers over the course of the previous year. In many of these instances, patients suffering from chronic pain became addicted to prescription opioids.
In addition to being highly addictive, many studies suggest that prescription opioids do not effectively control pain over the long term, and hence researchers have been exploring various alternatives, including cannabidiol (CBD). CBD is a non-psychoactive substance derived from the Cannabis plant.
Pennsylvania
United-states
United-kingdom
Philadelphia
Americans
British
Douglase-brenneman
Danielj-farkas
Lanam-huynh
Jefferyd-foss
Williama-kinney
vimarsana © 2020. All Rights Reserved.